A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
Clinical trial NCT01378962 · COMPLETED
Trial details
- NCT number
- NCT01378962
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-31
- Primary completion
- 2013-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.